目次

Table of Contents

Executive Summary
Market Overview

Market Landscape
Market ecosystem
Value chain analysis

Market Sizing
Market definition
Market segment analysis
Market size 2020
Market outlook: Forecast for 2020 - 2025

Five Forces Analysis
Five forces summary
Bargaining power of buyers
Bargaining power of suppliers
Threat of new entrants
Threat of substitutes
Threat of rivalry
Market condition

Market Segmentation by Product
Market segments
Comparison by Product
Broad-spectrum antibiotics - Market size and forecast 2020-2025
Narrow-spectrum antibiotics - Market size and forecast 2020-2025
Market opportunity by Product

Customer landscape

Geographic Landscape
Geographic segmentation
Geographic comparison
Asia - Market size and forecast 2020-2025
North America - Market size and forecast 2020-2025
Europe - Market size and forecast 2020-2025
ROW - Market size and forecast 2020-2025
Key leading countries
Market opportunity by geography
Market drivers
Market challenges
Market trends

Vendor Landscape
Overview
Vendor landscape
Landscape disruption

Vendor Analysis
Vendors covered
Market positioning of vendors
Abbott Laboratories
AbbVie Inc.
AstraZeneca Plc
Bayer AG
F. Hoffmann-La Roche Ltd.
Johnson & Johnson
Mayne Pharma Group Ltd.
Merck KGaA
Pfizer Inc.
Sanofi SA

Appendix
Scope of the report
Currency conversion rates for US$
Research methodology
List of abbreviations

Exhibits
1: Key Finding 1
2: Key Finding 2
3: Key Finding 3
4: Key Finding 5
5: Key Finding 6
6: Key Finding 7
7: Key Finding 8
8: Parent market
9: Market characteristics
10: Offerings of vendors included in the market definition
11: Market segments
12: Global - Market size and forecast 2020 - 2025 ($ million)
13: Global market: Year-over-year growth 2020 - 2025 (%)
14: Five forces analysis 2020 & 2025
15: Bargaining power of buyers
16: Bargaining power of suppliers
17: Threat of new entrants
18: Threat of substitutes
19: Threat of rivalry
20: Market condition - Five forces 2020
21: Product - Market share 2020-2025 (%)
22: Comparison by Product
23: Broad-spectrum antibiotics - Market size and forecast 2020-2025 ($ million)
24: Broad-spectrum antibiotics - Year-over-year growth 2020-2025 (%)
25: Narrow-spectrum antibiotics - Market size and forecast 2020-2025 ($ million)
26: Narrow-spectrum antibiotics - Year-over-year growth 2020-2025 (%)
27: Market opportunity by Product
28: Customer landscape
29: Market share by geography 2020-2025 (%)
30: Geographic comparison
31: Asia - Market size and forecast 2020-2025 ($ million)
32: Asia - Year-over-year growth 2020-2025 (%)
33: North America - Market size and forecast 2020-2025 ($ million)
34: North America - Year-over-year growth 2020-2025 (%)
35: Europe - Market size and forecast 2020-2025 ($ million)
36: Europe - Year-over-year growth 2020-2025 (%)
37: ROW - Market size and forecast 2020-2025 ($ million)
38: ROW - Year-over-year growth 2020-2025 (%)
39: Key leading countries
40: Market opportunity by geography ($ million)
41: Impact of drivers and challenges
42: Vendor landscape
43: Landscape disruption
44: Industry risks
45: Vendors covered
46: Market positioning of vendors
47: Abbott Laboratories - Overview
48: Abbott Laboratories - Business segments
49: Abbott Laboratories - Key offerings
50: Abbott Laboratories - Key customers
51: Abbott Laboratories - Segment focus
52: AbbVie Inc. - Overview
53: AbbVie Inc. - Product and service
54: AbbVie Inc. - Key offerings
55: AbbVie Inc. - Key customers
56: AbbVie Inc. - Segment focus
57: AstraZeneca Plc - Overview
58: AstraZeneca Plc - Product and service
59: AstraZeneca Plc - Key offerings
60: AstraZeneca Plc - Key customers
61: AstraZeneca Plc - Segment focus
62: Bayer AG - Overview
63: Bayer AG - Business segments
64: Bayer AG - Key offerings
65: Bayer AG - Key customers
66: Bayer AG - Segment focus
67: F. Hoffmann-La Roche Ltd. - Overview
68: F. Hoffmann-La Roche Ltd. - Business segments
69: F. Hoffmann-La Roche Ltd. - Key offerings
70: F. Hoffmann-La Roche Ltd. - Key customers
71: F. Hoffmann-La Roche Ltd. - Segment focus
72: Johnson & Johnson - Overview
73: Johnson & Johnson - Business segments
74: Johnson & Johnson - Key offerings
75: Johnson & Johnson - Key customers
76: Johnson & Johnson - Segment focus
77: Mayne Pharma Group Ltd. - Overview
78: Mayne Pharma Group Ltd. - Business segments
79: Mayne Pharma Group Ltd. - Key offerings
80: Mayne Pharma Group Ltd. - Key customers
81: Mayne Pharma Group Ltd. - Segment focus
82: Merck KGaA - Overview
83: Merck KGaA - Business segments
84: Merck KGaA - Key offerings
85: Merck KGaA - Key customers
86: Merck KGaA - Segment focus
87: Pfizer Inc. - Overview
88: Pfizer Inc. - Business segments
89: Pfizer Inc. - Key offerings
90: Pfizer Inc. - Key customers
91: Pfizer Inc. - Segment focus
92: Sanofi SA - Overview
93: Sanofi SA - Business segments
94: Sanofi SA - Key offerings
95: Sanofi SA - Key customers
96: Sanofi SA - Segment focus
97: Currency conversion rates for US$
98: Research Methodology
99: Validation techniques employed for market sizing
100: Information sources
101: List of abbreviations